Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus - 11/08/12

Abstract |
Background |
The occurrence of erythema multiforme (EM)-like lesions in association with lupus erythematosus (LE) is often referred to as “Rowell syndrome” (RS). However, the existence of RS, or at least its nosographic independence from LE, is questioned. The association of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) with LE is also controversial.
Objective |
We sought to define the features of EM and SJS/TEN in the setting of LE.
Methods |
The worldwide literature on the topic was systematically collected and reviewed.
Results |
A total of 132 citations were found, from which 95 cases of EM-like lesions and 47 of SJS/TEN associated with LE were retrieved. Our analysis identified a subgroup defined as “subacute cutaneous LE (CLE)/acute CLE with EM-like lesions” and highlighted that this and subacute CLE/acute CLE with TEN-like lesions are variants of already known CLE subpatterns. On the other hand, RS can be considered an independent chronic CLE subtype characterized by the distinctive co-occurrence of chronic CLE and EM-like lesions and frequent, albeit mild, systemic involvement.
Limitations |
The study was based on retrospective data and the number of reported cases identified was relatively small.
Conclusion |
RS might be included as a chronic CLE subtype within the spectrum of LE-specific skin disease.
El texto completo de este artículo está disponible en PDF.Key words : erythema multiforme, lupus erythematosus, Rowell syndrome, Stevens-Johnson syndrome, systematic review, toxic epidermal necrolysis
Abbreviations used : ACLE, CCLE, CLE, DIF, DLE, EM, LE, RS, SCLE, SJS, SLE, TEN
Esquema
| Dr Torchia was funded in part by a fellowship awarded by the Società Italiana di Dermatologia e Malattie Sessualmente Trasmesse. |
|
| Disclosure: Dr Kerdel is on the advisory board and served as a speaker for Genetech, Astellas, Abbott, Centocor, and Amgen; he has also received research grants from the latter 3 companies. Drs Torchia and Romanelli have no conflicts of interest to declare. |
Vol 67 - N° 3
P. 417-421 - septembre 2012 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
